PATENT CLAIM ANALYSIS

Application Number: 16282199
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "269100"]

Abstract:
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.

Claim (Index 42):
A method of increasing survival of a subject afflicted with a disease or disorder selected from the group consisting of severe cerebral malaria, experimental cerebral malaria, sepsis, dengue, hemorrhagic fever, toxic shock syndrome, hemorrhagic shock, hemolytic uremic syndrome, myocardial infarction and stroke, the method comprising administering a pharmaceutical composition comprising a therapeutically effective amount of an exogenous modified angiopoietin protein to the subject in need thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.2973
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15414925', '14529677', '15949472', '15773498', '15820943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991640794096033
- 35 USC 102 Novelty (BERT): 0.6245153380791628
- Combined Prediction Score: 0.7816992052765592
- Mean Citation Score: 524.846092
- Max Citation Score: 677.586
- Similarity Product: 513.2197348315716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test